| 2024 |
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study
10.1055/a-2259-0662
Authors: A. Cohen, C. Wallenhorst, M. Rivera, C. Ay, B. Schaefer, K. Abdelgawwad, G. Psaroudakis, G. Brobert, A. Ekbom, A. Y. Y. Lee, A. Khorana, C. Becattini, M. Carrier, C. Coleman, C. Martinez |
| 2024 |
Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study
10.1136/bmjmed-2022-000474
Authors: T. Beaney, J. Clarke, T. Woodcock, A. Majeed, M. Barahona, P. Aylin |
| 2024 |
Population-based study of alcohol-related liver disease in England 2001-2018: Influence of socioeconomic position
10.14309/ajg.0000000000002677
Authors: G. Askgaard, P. Jepsen, M. Jensen, A. Kann, J. Morling, F. Kraglund, T. Card, C. Crooks, J. West |
| 2024 |
Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study
10.1161/strokeaha.123.045098
Authors: R. Chiv, S. Beradid, S. Suissa, C. Renoux |
| 2024 |
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
10.1136/rmdopen-2023-003980
Authors: A. Abhishek, M. Grainge, T. Card, H. Williams, M. Taal, G. Aithal, C. Fox, C. Mallen, M. Stevenson, G. Nakafero, R. Riley |
| 2024 |
Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study
10.1093/rheumatology/keae160
Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, J. Van-Tam, A. Abhishek |
| 2024 |
Prodromal symptoms of rheumatoid arthritis in a primary care database: variation by ethnicity and socioeconomic status
10.1093/rheumatology/keae157
Authors: A. D'Elia, A. Baranskaya, S. Haroon, B. Hammond, N. Adderley, K. Nirantharakumar, J. Chandan, M. Falahee, K. Raza |
| 2024 |
Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study
10.1097/inf.0000000000004213
Authors: J. Yang, K. Andersen, K. Rai, T. Tritton, T. Mugwagwa, C. Tsang, M. Reimbaeva, L. McGrath, P. Payne, B. Backhouse, D. Mendes, R. Butfield, R. Wood, J. Nguyen |
| 2024 |
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls
10.1016/s2665-9913(23)00338-7
Authors: L. Ferguson, G. Molenberghs, G. Verbeke, K. Rahimi, S. Rao, I. McInnes, J. McMurray, N. Sattar, N. Conrad |
| 2024 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
10.1016/s2213-2600(23)00414-9
Authors: M. Català, N. Mercadé-Besora, R. Kolde, N. Trinh, E. Roel, E. Burn, T. Rathod-Mistry, K. Kostka, W . Y. Man, A. Delmestri, H. Nordeng, A. Uusküla, T. Duarte-Salles, D. Prieto-Alhambra, A. Jödicke |
| 2024 |
Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records
10.1016/s2666-7568(23)00285-4
Authors: E. Buzasi, H. Carreira, G. Funston, K. Mansfield, H. Forbes, H. Strongman, K. Bhaskaran |
| 2024 |
Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding
10.1001/jamanetworkopen.2024.3208
Authors: A. Rahman, R. Platt, S. Beradid, J. Boivin, S. Rej, C. Renoux |
| 2024 |
Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study
10.1016/j.jinf.2024.106135
Authors: A. Lalmohamed, R. Venekamp, A. Bolhuis, P. Souverein, Jhhm van de Wijgert, M. Gulliford, A. Hay |
| 2024 |
The risk of acute infections in new users of antidepressants: An observational cohort study
10.1016/j.jad.2024.03.002
Authors: N. Aebi, C. Meier, S. Jick, U. Lang, J. Spoendlin |
| 2024 |
Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study
10.1016/j.ijid.2024.01.002
Authors: S. Ghosh, A. Antunes, H. Rinta-Kokko, E. Chaparova, S. Lay-Flurrie, A. Tricotel, F. Andersson |
| 2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
10.1093/ehjcvp/pvae022
Authors: T. Eroglu, R. Coronel, P. Souverein |
| 2024 |
Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data
10.1016/j.diabres.2024.111641
Authors: I. Carey, J. Critchley, A. U, D. Cook, S. DeWilde, E. Limb, L. Bowen, S. Woolford, P. Whincup, N. Sattar, A. Panahloo, T. Harris |
| 2024 |
Ethnic differences in depression and anxiety among adults with atopic eczema: Population-based matched cohort studies within UK primary care
10.1002/clt2.12348
Authors: E. Adesanya, A. Henderson, J. Hayes, A. Lewin, R. Mathur, A. Mulick, C. Morton, C. Smith, S. Langan, K. Mansfield |
| 2024 |
Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study
10.1016/j.canep.2024.102552
Authors: C. Cardwell, R. McDowell, C. Hughes, J. Busby, P. Murchie |
| 2024 |
Post-hospitalisation asthma management in primary care: a retrospective cohort study
10.3399/bjgp.2023.0214
Authors: D. Punyadasa, N. Simms-Williams, N. Adderley, R. Thayakaran, A. Mansur, K. Nirantharakumar, P. Nagakumar, S. Haroon |
| 2024 |
Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
10.1093/bjd/ljae133
Authors: V. Eleftheriadou, C. Delattre, S. Chetty-Mhlanga, C. Lee, L. Girardat-Rotar, I. Khan, A. Mathew, A. Thompson |
| 2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
10.1111/bcp.16039
Authors: S. Shapiro, H. Yin, O. H. Y. Yu, L. Azoulay |
| 2024 |
How common are side effects of treatment to prevent gout flares when starting allopurinol?
10.1136/bmj.q514
Authors: H. Saul, B. Deeney, L. Swaithes, E. Roddy |
| 2024 |
Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort
10.1186/s12874-024-02175-9
Authors: H. Harrison, S. Ip, C. Renzi, Y. Li, M. Barclay, J. Usher-Smith, G. Lyratzopoulos, A. Wood, A. Antoniou |
| 2024 |
Comparing the clinical practice and prescribing safety of locum and permanent doctors: observational study of primary care consultations in England
10.1186/s12916-024-03332-z
Authors: C. Grigoroglou, K. Walshe, E. Kontopantelis, J. Ferguson, G. Stringer, D. Ashcroft, T. Allen |
| 2024 |
Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK
10.1186/s12916-024-03283-5
Authors: L. Down, M. Barlow, S. Bailey, L. Mounce, S. Merriel, J. Watson, T. Martins |
| 2024 |
Risk calculator for incident atrial fibrillation across a range of prediction horizons
10.1016/j.ahj.2024.03.001
Authors: J. Wu, R. Nadarajah, Y. Nakao, K. Nakao, R. Arbel, M. Haim, D. Zahger, G. Lip, J. Cowan, C. Gale |
| 2024 |
Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study
10.1002/alz.13561
Authors: A. Douros, Z. Ante, C. Fallone, L. Azoulay, C. Renoux, S. Suissa, P. Brassard |
